To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FUSTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
782 representative clones for gene FUS back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW249142 lung, small cell carcinoma .a 1 to 561 9 to 569       569/569
(100 %)
7 diff
(98.8 %id)
CR598388 fetal liver .a 1 to 1780 6 to 1785   tiling clone,   1785/1785
(100 %)
0 diff
(100 %id)
BX405618 fetal liver, Liver .a 1 to 889 6 to 894   fully sequenced,   894/894
(100 %)
5 diff
(99.5 %id)
CB854656 lung .a 253 to 967 716 to 4       713/722
(98 %)
2 diff
(99.8 %id)
BQ304667 breast .a 564 to 936 382 to 8       354/382
(92 %)
6 diff
(98.5 %id)
BE258944 eye, retinoblastoma .a 597 to 1282 35 to 733       675/739
(91 %)
41 diff
(94.5 %id)
BE253563 eye, retinoblastoma .a 637 to 1278 1 to 670       645/673
(95 %)
85 diff
(87.4 %id)
BX423936 neuroblastoma .a 788 to 1742 974 to 23       934/955
(97 %)
25 diff
(97.4 %id)
BX405617 fetal liver, Liver .a 826 to 1780 952 to 1   fully sequenced,   955/955
(100 %)
7 diff
(99.3 %id)
AW248715 lung, small cell carcinoma .a 1502 to 1807 316 to 11   tiling clone, AAA   306/306
(100 %)
0 diff
(100 %id)
NM_004960.3   .b 1 to 5119 1 to 5119 exact RefSeq,   5119/5119
(100 %)
0 diff
(100 %id)
CR591758 fetal brain .b 23 to 1818 1 to 1796 exact tiling clone,   1796/1796
(100 %)
0 diff
(100 %id)
BX423519 brain, fetal brain .b 23 to 900 1 to 880   fully sequenced,   880/880
(100 %)
4 diff
(99.6 %id)
S62138   .b 28 to 904 1 to 877       877/1682
(52 %)
3 diff
(99.9 %id)
S62140   .b 28 to 1850 1 to 1824 exact     1824/1824
(100 %)
3 diff
(99.9 %id)
AK290936   .b 30 to 1850 1 to 1818 G111V G193Y Y194G G195N N196Q ...     1818/1818
(100 %)
4 diff
(99.8 %id)
BC000402 Lung, small cell carcinoma .b 38 to 1850 1 to 1813 exact available from MGC, AAA   1813/1813
(100 %)
2 diff
(99.9 %id)
TI_1948244484   .b 38 to 904 199 to 1065       867/1228
(70 %)
13 diff
(99.0 %id)
BX461367 brain, fetal brain .b 39 to 937 1 to 901       901/901
(100 %)
8 diff
(99.2 %id)
BX426378 B cells (Ramos cell line) .b 41 to 904 1 to 865       865/865
(100 %)
22 diff
(97.5 %id)
BX447044 neuroblastoma .b 43 to 901 1 to 858       858/858
(100 %)
6 diff
(99.4 %id)
CR608658 Neuroblastoma Cot 25-normalized .b 43 to 1810 1 to 1768 exact     1768/1768
(100 %)
0 diff
(100 %id)
AL528104 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 43 to 973 1 to 930   fully sequenced,   930/930
(100 %)
3 diff
(99.7 %id)
BX417850 placenta .b 43 to 932 1 to 889       889/889
(100 %)
5 diff
(99.5 %id)
BX441304 brain, fetal brain .b 43 to 986 1 to 949       949/949
(100 %)
10 diff
(99.0 %id)
BX420023 brain, fetal brain .b 43 to 905 1 to 859       859/975
(88 %)
9 diff
(99.1 %id)
AL539420 brain, fetal brain .b 43 to 988 1 to 937       938/971
(96 %)
25 diff
(97.5 %id)
BX443211 B cells (Ramos cell line) .b 43 to 978 1 to 935       935/935
(100 %)
4 diff
(99.6 %id)
AL549027 placenta, Placenta Cot 25-normalized .b 43 to 904 1 to 864       864/864
(100 %)
3 diff
(99.7 %id)
CR621237 neuroblastoma .b 45 to 1822 1 to 1778 exact     1778/1778
(100 %)
0 diff
(100 %id)
AL518471 brain, neuroblastoma, neuroblastoma cells .b 45 to 934 1 to 890   fully sequenced,   890/890
(100 %)
8 diff
(99.2 %id)
CR599479 neuroblastoma .b 46 to 1821 1 to 1776 exact     1776/1776
(100 %)
0 diff
(100 %id)
CR618073 Placenta Cot 25-normalized .b 46 to 1999 1 to 1954 exact     1954/1954
(100 %)
0 diff
(100 %id)
BX437943 neuroblastoma .b 46 to 1006 1 to 957       957/978
(97 %)
38 diff
(96.2 %id)
AL518191 brain, neuroblastoma, neuroblastoma cells .b 46 to 922 1 to 877       877/980
(89 %)
28 diff
(97.2 %id)
BX447274 neuroblastoma .b 46 to 1040 1 to 995       995/995
(100 %)
15 diff
(98.5 %id)
BX438773 placenta .b 46 to 996 1 to 950       950/950
(100 %)
3 diff
(99.7 %id)
AL545722 placenta, Placenta Cot 25-normalized .b 46 to 935 1 to 891   fully sequenced,   891/891
(100 %)
5 diff
(99.5 %id)
BX459161 placenta .b 47 to 933 1 to 885       885/885
(100 %)
11 diff
(98.8 %id)
BC026062 Lung, small cell carcinoma .b 48 to 1850 1 to 1803 Y33H available from MGC, AAA   1803/1803
(100 %)
3 diff
(99.9 %id)
CR602284 fetal brain .b 53 to 2054 1 to 2002 exact tiling clone,   2002/2002
(100 %)
0 diff
(100 %id)
CR626591 neuroblastoma .b 53 to 2000 1 to 1948 exact     1948/1948
(100 %)
0 diff
(100 %id)
BX445469 neuroblastoma .b 53 to 996 1 to 943       943/943
(100 %)
18 diff
(98.1 %id)
BX457595 neuroblastoma .b 53 to 1039 1 to 983       983/983
(100 %)
8 diff
(99.2 %id)
AL518917 brain, neuroblastoma, neuroblastoma cells .b 53 to 1072 1 to 1014   fully sequenced,   1014/1014
(100 %)
10 diff
(99.1 %id)
AL534822 brain, fetal brain .b 53 to 1038 1 to 986   fully sequenced,   986/986
(100 %)
3 diff
(99.7 %id)
BX460459 brain, fetal brain .b 53 to 974 36 to 957       922/957
(96 %)
7 diff
(99.3 %id)
BM455091 lymph, lymphoma, cell line .b 63 to 905 1 to 845       845/1100
(76 %)
23 diff
(98.0 %id)
BC002459 Lymph, Burkitt lymphoma .b 66 to 1850 1 to 1785 exact available from MGC, AAA   1785/1785
(100 %)
1 diff
(100.0 %id)
CD518640 White Matter .b 66 to 901 1 to 849       845/881
(95 %)
11 diff
(98.8 %id)
BQ882415 brain, neuroblastoma, cell line .b 71 to 905 1 to 845       845/948
(89 %)
25 diff
(97.4 %id)
BT007131   .b 106 to 1685 1 to 1580       1580/1581
(99 %)
2 diff
(99.9 %id)
CR456747   .b 106 to 1686 1 to 1581 exact     1581/1581
(100 %)
0 diff
(100 %id)
CR626089 Placenta Cot 25-normalized .b 119 to 1845 1 to 1727       1727/1727
(100 %)
0 diff
(100 %id)
BX399941 Placenta Cot 25-normalized .b 119 to 1037 1 to 927       927/927
(100 %)
43 diff
(95.4 %id)
BQ072066 brain, neuroblastoma, cell line .b 147 to 936 1 to 800       800/1079
(74 %)
15 diff
(98.7 %id)
BG028792 Bone, osteosarcoma, cell line .b 205 to 905 1 to 696       696/925
(75 %)
11 diff
(98.9 %id)
BX423518 brain, fetal brain .b 869 to 1818 949 to 1   fully sequenced,   949/949
(100 %)
1 diff
(99.9 %id)
AL518470 brain, neuroblastoma, neuroblastoma cells .b 874 to 1822 947 to 1   fully sequenced,   947/947
(100 %)
32 diff
(96.7 %id)
AL571333 placenta, Placenta Cot 25-normalized .b 874 to 1994 1126 to 6   fully sequenced,   1121/1126
(99 %)
3 diff
(99.8 %id)
AL573377 placenta, Placenta Cot 25-normalized .b 905 to 1822 920 to 1       917/920
(99 %)
3 diff
(99.7 %id)
AL528103 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 943 to 1810 870 to 1   fully sequenced,   870/870
(100 %)
18 diff
(98.0 %id)
AL565673 brain, fetal brain .b 1011 to 2054 1038 to 1   fully sequenced,   1038/1038
(100 %)
1 diff
(100.0 %id)
BX455416 brain, fetal brain .b 1027 to 1845 821 to 1       821/905
(90 %)
15 diff
(98.4 %id)
AL518916 brain, neuroblastoma, neuroblastoma cells .b 1028 to 2000 976 to 1   fully sequenced,   976/976
(100 %)
18 diff
(98.2 %id)
BX412455 placenta .b 1028 to 1845 820 to 1       820/890
(92 %)
13 diff
(98.6 %id)
BX434396 placenta .b 1057 to 1820 776 to 10       767/854
(89 %)
17 diff
(98.1 %id)
BX414055 B cells (Ramos cell line) .b 1156 to 1845 693 to 4       690/932
(74 %)
26 diff
(97.3 %id)
BX454149 neuroblastoma .b 1219 to 1845 628 to 1       628/727
(86 %)
18 diff
(97.6 %id)
AL539419 brain, fetal brain .b 1272 to 2012 750 to 10       741/750
(98 %)
10 diff
(98.7 %id)
NM_001170634.1   .c 1 to 5116 1 to 5116 exact RefSeq,   5116/5116
(100 %)
0 diff
(100 %id)
DA362152 subthalamic nucleus .c 28 to 605 2 to 578   capped   577/577
(100 %)
5 diff
(99.2 %id)
BP265956 thyroid .c 29 to 606 1 to 578   tiling clone,   578/578
(100 %)
4 diff
(99.4 %id)
BP266256 thyroid .c 29 to 607 1 to 579       579/579
(100 %)
4 diff
(99.4 %id)
DA821302 pericardium .c 29 to 596 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
AK098774 brain .c 30 to 1847 1 to 1818 Y396N available from FLJ,   1818/1818
(100 %)
3 diff
(99.9 %id)
DA197259 brain .c 30 to 711 2 to 684   capped   683/683
(100 %)
5 diff
(99.3 %id)
BP209726 cerebellum .c 30 to 614 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BP265695 thyroid .c 30 to 613 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP374496 umbilical cord .c 30 to 610 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA131545 alzheimer cortex .c 31 to 661 2 to 632   capped   631/631
(100 %)
2 diff
(99.7 %id)
DA205578 brain .c 31 to 618 2 to 589   capped   588/588
(100 %)
5 diff
(99.2 %id)
DA341201 substantia nigra .c 31 to 606 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA385375 thalamus .c 31 to 610 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DA487343 brain .c 31 to 611 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DA672124   .c 31 to 617 2 to 588   capped   587/587
(100 %)
4 diff
(99.4 %id)
DA751480   .c 31 to 605 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA930075 small intestine .c 31 to 621 2 to 592   capped   591/591
(100 %)
3 diff
(99.5 %id)
DA085478 cerebellum .c 32 to 612 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DA253128 caudate nucleus .c 33 to 619 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA549847   .c 33 to 616 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
BM478291 eye, retinoblastoma .c 33 to 844 32 to 856       821/1240
(66 %)
37 diff
(97.1 %id)
DA618880   .c 33 to 611 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DB109556 thymus .c 33 to 611 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DB191360 lung, tumor tissue .c 33 to 617 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DC340659 thalamus .c 34 to 468 1 to 435       435/435
(100 %)
2 diff
(99.6 %id)
BP211756 cerebrum .c 34 to 611 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
DB242238 stomach, tumor tissue .c 34 to 611 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA287185 corpus callosum .c 35 to 614 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BX405782 fetal liver, Liver .c 39 to 866 1 to 829       829/829
(100 %)
17 diff
(98.0 %id)
TI_59379851   .c 39 to 622 111 to 719   AAA   607/1008
(60 %)
42 diff
(95.9 %id)
CT001764 T-Lymphocytes .c 40 to 925 1 to 885       885/885
(100 %)
4 diff
(99.6 %id)
CR979922 T-Lymphocytes .c 40 to 649 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
CR996250 T-Lymphocytes .c 40 to 674 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
CR615094 fetal brain .c 41 to 1819 1 to 1779 exact     1779/1779
(100 %)
0 diff
(100 %id)
AL534787 brain, fetal brain .c 41 to 932 1 to 895   fully sequenced,   895/895
(100 %)
4 diff
(99.6 %id)
BX460947 brain, fetal brain .c 41 to 970 1 to 929       929/929
(100 %)
3 diff
(99.7 %id)
BP237114 coronary artery .c 41 to 619 1 to 579       579/581
(99 %)
5 diff
(99.2 %id)
CT001532 T-Lymphocytes .c 41 to 670 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
BQ720219 sympathetic trunk .c 42 to 713 1 to 673       673/999
(67 %)
12 diff
(98.8 %id)
BX463893 brain, fetal brain .c 43 to 1014 1 to 964       964/969
(99 %)
15 diff
(98.5 %id)
BX460470 brain, fetal brain .c 43 to 965 1 to 922       922/922
(100 %)
3 diff
(99.7 %id)
AL543304 placenta, Placenta Cot 25-normalized .c 43 to 897 1 to 855   fully sequenced,   855/855
(100 %)
2 diff
(99.8 %id)
BG819343 anaplastic oligodendroglioma with 1p/19qloss, brain .c 43 to 822 1 to 781       781/781
(100 %)
11 diff
(98.6 %id)
BQ069083 brain, neuroblastoma, cell line .c 43 to 865 1 to 825       825/998
(82 %)
43 diff
(95.7 %id)
BQ070290 brain, neuroblastoma, cell line .c 43 to 867 1 to 839       839/1009
(83 %)
41 diff
(96.0 %id)
BQ685528 ductal carcinoma, cell line, Pancreas .c 43 to 836 1 to 796       796/914
(87 %)
14 diff
(98.5 %id)
BQ898939 brain, neuroblastoma, cell line .c 43 to 866 1 to 830       830/913
(90 %)
15 diff
(98.4 %id)
BU148792 brain, neuroblastoma, cell line .c 43 to 848 1 to 822       822/935
(87 %)
32 diff
(96.6 %id)
BU845660 ovary, teratocarcinoma, cell line .c 43 to 867 1 to 841       841/956
(87 %)
30 diff
(96.9 %id)
BU855737 ovary, teratocarcinoma, cell line .c 43 to 871 1 to 839       839/947
(88 %)
23 diff
(97.6 %id)
CR986156 T-Lymphocytes .c 43 to 772 1 to 730       730/730
(100 %)
2 diff
(99.8 %id)
CR993614 T-Lymphocytes .c 43 to 824 1 to 782       782/782
(100 %)
2 diff
(99.8 %id)
CR994550 T-Lymphocytes .c 43 to 713 1 to 672       672/673
(99 %)
4 diff
(99.5 %id)
X71428   .c 43 to 1850 10 to 1817 exact tiling clone,   1808/1822
(99 %)
8 diff
(99.6 %id)
BX447611 B cells (Ramos cell line) .c 45 to 901 1 to 857       857/857
(100 %)
4 diff
(99.6 %id)
BM479836 eye, retinoblastoma .c 45 to 866 1 to 824       824/1051
(78 %)
16 diff
(98.5 %id)
BM803690 leiomyosarcoma, uterus .c 45 to 825 1 to 794       794/1128
(70 %)
28 diff
(97.6 %id)
BQ440932 leiomyosarcoma, uterus .c 45 to 866 1 to 828       828/877
(94 %)
20 diff
(97.8 %id)
CR975138 T-Lymphocytes .c 46 to 704 1 to 661       661/661
(100 %)
5 diff
(99.3 %id)
DA151992 amygdala .c 47 to 629 2 to 584   capped   583/583
(100 %)
7 diff
(98.8 %id)
AL515993 brain, neuroblastoma, neuroblastoma cells .c 47 to 932 1 to 885   fully sequenced,   885/885
(100 %)
7 diff
(99.3 %id)
CN351619 embryonic stem cells, cell lines H1, H7, andH9 .c 48 to 675 13 to 641       627/641
(97 %)
8 diff
(98.8 %id)
CR618104 neuroblastoma .c 48 to 1832 1 to 1785 exact tiling clone,   1785/1785
(100 %)
0 diff
(100 %id)
CR979523 T-Lymphocytes .c 48 to 837 1 to 790       790/792
(99 %)
3 diff
(99.7 %id)
BU931722 ovary, teratocarcinoma, cell line .c 50 to 794 1 to 752       752/911
(82 %)
14 diff
(98.5 %id)
CN351594 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 51 to 713 1 to 663       663/663
(100 %)
3 diff
(99.6 %id)
BQ879295 dorsal root ganglia .c 51 to 782 1 to 737       737/937
(78 %)
28 diff
(97.1 %id)
CR988215 T-Lymphocytes .c 51 to 750 1 to 704       704/705
(99 %)
12 diff
(98.3 %id)
CR982049 T-Lymphocytes .c 52 to 825 1 to 775       775/777
(99 %)
4 diff
(99.5 %id)
BF528174 anaplastic oligodendroglioma with 1p/19qloss, brain .c 53 to 775 1 to 719   AAA   719/897
(80 %)
23 diff
(97.5 %id)
BQ062631 lymph, lymphoma, cell line .c 53 to 966 1 to 926       923/1043
(88 %)
21 diff
(98.0 %id)
BU855397 ovary, teratocarcinoma, cell line .c 53 to 866 1 to 825       825/870
(94 %)
17 diff
(98.1 %id)
BM051476 Burkitt lymphoma, lymph .c 54 to 731 1 to 678       678/678
(100 %)
5 diff
(99.3 %id)
TI_57199243   .c 54 to 886 47 to 891       841/895
(93 %)
30 diff
(96.7 %id)
CR992870 T-Lymphocytes .c 55 to 698 1 to 642       642/647
(99 %)
6 diff
(99.1 %id)
CT001244 T-Lymphocytes .c 55 to 815 1 to 762       762/763
(99 %)
3 diff
(99.7 %id)
CR980282 T-Lymphocytes .c 58 to 732 1 to 676       676/678
(99 %)
3 diff
(99.6 %id)
BE294284 muscle, rhabdomyosarcoma .c 60 to 703 1 to 642       642/646
(99 %)
5 diff
(99.3 %id)
BE729454 melanotic melanoma, skin .c 60 to 792 1 to 720       720/961
(74 %)
21 diff
(97.9 %id)
BE270236 Burkitt lymphoma, lymph .c 61 to 689 1 to 629       629/630
(99 %)
3 diff
(99.6 %id)
BE729885 melanotic melanoma, skin .c 61 to 873 1 to 817       817/945
(86 %)
36 diff
(96.2 %id)
CN351595 embryonic stem cells, DMSO-treated H9 cellline .c 62 to 679 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
BE783504 eye, retinoblastoma .c 62 to 789 1 to 722       722/750
(96 %)
15 diff
(98.0 %id)
BQ937575 leiomyosarcoma, uterus .c 67 to 831 1 to 767       767/935
(82 %)
11 diff
(98.9 %id)
BE799920 lung, small cell carcinoma .c 82 to 829 48 to 798       751/798
(94 %)
19 diff
(97.7 %id)
BE794983 lung, small cell carcinoma .c 88 to 902 1 to 817       817/997
(81 %)
6 diff
(99.4 %id)
DB038580 testis .c 91 to 666 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
TI_149286957   .c 230 to 1007 829 to 51       776/1185
(65 %)
11 diff
(99.1 %id)
CT005094 T-Lymphocytes .c 241 to 826 1 to 586       586/588
(99 %)
2 diff
(99.7 %id)
BU860024 adenocarcinoma, cell line, breast .c 310 to 1035 1 to 737       737/952
(77 %)
22 diff
(97.7 %id)
BQ882038 brain, neuroblastoma, cell line .c 335 to 1222 25 to 928       904/950
(95 %)
30 diff
(96.9 %id)
CX165798 human embryonic stem cells differentiated toan early endodermal cell type .c 339 to 969 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BM477335 lymph, lymphoma, cell line .c 353 to 999 30 to 679       650/1198
(54 %)
14 diff
(98.9 %id)
S75762 myxoid liposarcoma .c 355 to 901 1 to 546       546/652
(83 %)
2 diff
(99.7 %id)
BQ223832 embryonal carcinoma, cell line, testis .c 367 to 1171 1 to 812       812/886
(91 %)
11 diff
(98.8 %id)
CR993133 T-Lymphocytes .c 404 to 996 1 to 593       593/595
(99 %)
1 diff
(99.9 %id)
BU500982 eye, normal pigmented retinal epithelium .c 479 to 1269 1 to 791       791/889
(88 %)
4 diff
(99.6 %id)
BG821719 adenocarcinoma cell line, colon .c 505 to 1192 1 to 692       692/692
(100 %)
10 diff
(98.6 %id)
CN351677 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 515 to 1195 8 to 688       681/688
(98 %)
10 diff
(98.6 %id)
TI_57186553   .c 532 to 1393 51 to 916       866/866
(100 %)
23 diff
(97.4 %id)
BI856071 breast, mammary adenocarcinoma, cell line .c 534 to 1393 1 to 864       864/864
(100 %)
23 diff
(97.4 %id)
CX781996 human embryonic stem cells .c 535 to 1248 1 to 714       714/714
(100 %)
2 diff
(99.8 %id)
BU151582 Spleen .c 541 to 1401 1 to 879       879/889
(98 %)
31 diff
(96.6 %id)
BG388160 embryonal carcinoma, cell line, testis .c 572 to 1346 1 to 774       774/975
(79 %)
27 diff
(97.3 %id)
BM476232 duodenal adenocarcinoma, cell line, small intestine .c 599 to 1358 27 to 789       763/1100
(69 %)
13 diff
(98.9 %id)
CN351682 embryonic stem cells, DMSO-treated H9 cellline .c 613 to 926 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BF924954 nervous_tumor .c 620 to 929 310 to 1     Submitted on the opposite strand 310/310
(100 %)
0 diff
(100 %id)
AL569873 placenta, Placenta Cot 25-normalized .c 859 to 1818 954 to 1   fully sequenced,   954/954
(100 %)
18 diff
(98.2 %id)
AL515992 brain, neuroblastoma, neuroblastoma cells .c 871 to 1832 959 to 1   fully sequenced,   959/959
(100 %)
9 diff
(99.1 %id)
AL565657 brain, fetal brain .c 875 to 1816 943 to 5   fully sequenced,   939/943
(99 %)
8 diff
(99.2 %id)
BX447610 B cells (Ramos cell line) .c 901 to 1808 908 to 1       908/909
(99 %)
9 diff
(99.1 %id)
BX405781 fetal liver, Liver .c 942 to 1834 897 to 1       897/897
(100 %)
18 diff
(98.0 %id)
NM_001170937.1   .d 1 to 5107 1 to 5107 exact RefSeq,   5107/5107
(100 %)
0 diff
(100 %id)
DB114043 thymus .d 31 to 618 2 to 589   tiling clone, capped   588/588
(100 %)
2 diff
(99.7 %id)
BP343244 stomach mucosa .d 34 to 618 1 to 584   tiling clone,   584/584
(100 %)
3 diff
(99.5 %id)
U36561   .d 106 to 1667 1 to 1583   tiling clone,   1583/1583
(100 %)
80 diff
(95.0 %id)
BQ644872 hepatocellular carcinoma, cell line, Liver .d 616 to 1260 31 to 676   tiling clone,   646/953
(67 %)
12 diff
(98.8 %id)
BM478221 lymph, lymphoma, cell line .d 621 to 1493 1 to 872       872/989
(88 %)
17 diff
(98.3 %id)
DR761067 embryonic stem .d 623 to 1351 1 to 729   tiling clone,   729/729
(100 %)
0 diff
(100 %id)
BG751394 eye, normal pigmented retinal epithelium .d 625 to 1353 1 to 727       727/784
(92 %)
14 diff
(98.3 %id)
BQ670711 epidermoid carcinoma, cell line, salivary gland .d 625 to 1493 11 to 879       869/919
(94 %)
26 diff
(97.2 %id)
CN351598 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 627 to 1304 1 to 678       678/678
(100 %)
0 diff
(100 %id)
CN351631 embryonic stem cells, DMSO-treated H9 cellline .d 627 to 1314 1 to 688       688/688
(100 %)
0 diff
(100 %id)
BG333730 melanotic melanoma, skin .d 627 to 1385 1 to 756       756/969
(78 %)
17 diff
(98.3 %id)
BM801773 duodenal adenocarcinoma, cell line, small intestine .d 627 to 1457 1 to 843       843/947
(89 %)
18 diff
(98.1 %id)
BQ066751 lymph, lymphoma, cell line .d 627 to 1494 1 to 873       873/1035
(84 %)
22 diff
(97.9 %id)
BU193007 eye, retinoblastoma .d 627 to 1262 1 to 637       637/833
(76 %)
5 diff
(99.4 %id)
CV815568 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 627 to 1466 1 to 845       845/883
(95 %)
20 diff
(97.8 %id)
BG164298 hypernephroma, cell line, Kidney .d 628 to 1391 1 to 754       754/969
(77 %)
59 diff
(94.0 %id)
BG121513 adenocarcinoma, cell line, Liver .d 628 to 1353 1 to 726       726/766
(94 %)
10 diff
(98.7 %id)
BI333818 cervical carcinoma cell line, cervix .d 628 to 1262 1 to 635       635/642
(98 %)
1 diff
(99.9 %id)
DR156312 human embryonic stem cells differentiated toan early endodermal cell type .d 628 to 1311 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
DR158189 human embryonic stem cells differentiated toan early endodermal cell type .d 628 to 1311 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
DR762959 embryonic stem .d 628 to 1238 1 to 611       611/611
(100 %)
3 diff
(99.6 %id)
CN351628 embryonic stem cells, cell lines H1, H7, andH9 .d 629 to 1279 1 to 650       650/650
(100 %)
3 diff
(99.6 %id)
BM011858 brain, neuroblastoma, cell line .d 629 to 1295 1 to 667       667/667
(100 %)
2 diff
(99.8 %id)
BQ070184 brain, neuroblastoma, cell line .d 629 to 1494 1 to 871       871/990
(87 %)
22 diff
(97.8 %id)
CN351600 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 630 to 1253 1 to 622       622/622
(100 %)
4 diff
(99.4 %id)
BM553835 duodenal adenocarcinoma, cell line, small intestine .d 630 to 1466 1 to 842       842/1008
(83 %)
28 diff
(97.3 %id)
BQ669725 epidermoid carcinoma, cell line, salivary gland .d 630 to 1326 1 to 698       698/953
(73 %)
10 diff
(99.0 %id)
BQ668654 epidermoid carcinoma, cell line, salivary gland .d 630 to 1385 1 to 760       760/918
(82 %)
14 diff
(98.5 %id)
BQ919041 carcinoma, cell line, Prostate .d 630 to 1478 1 to 870       870/945
(92 %)
32 diff
(96.7 %id)
CN351648 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 631 to 1316 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BI850586 lymph, lymphoma, cell line .d 631 to 1270 1 to 641       641/643
(99 %)
15 diff
(97.7 %id)
CX786014 human embryonic stem cells .d 631 to 1311 1 to 681       681/681
(100 %)
0 diff
(100 %id)
TI_44385128   .d 631 to 1339 37 to 745       709/709
(100 %)
5 diff
(99.3 %id)
TI_59381038   .d 631 to 1295 103 to 767       665/665
(100 %)
0 diff
(100 %id)
TI_59381419   .d 631 to 1328 88 to 798       711/788
(90 %)
31 diff
(96.1 %id)
BG111029 Bone, osteosarcoma, cell line .d 632 to 1262 1 to 632       632/673
(93 %)
6 diff
(99.2 %id)
BG177857 lymph, lymphoma, cell line .d 632 to 1400 1 to 760       760/975
(77 %)
22 diff
(97.8 %id)
BI260207 cervical carcinoma cell line, cervix .d 632 to 1340 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
BM471477 melanotic melanoma, skin .d 632 to 1385 1 to 758       758/1062
(71 %)
13 diff
(98.8 %id)
BQ669334 epidermoid carcinoma, cell line, salivary gland .d 632 to 1385 1 to 776       776/988
(78 %)
64 diff
(93.6 %id)
BQ670536 epidermoid carcinoma, cell line, salivary gland .d 632 to 1355 1 to 732       732/856
(85 %)
15 diff
(98.3 %id)
CX165140 human embryonic stem cells differentiated toan early endodermal cell type .d 632 to 1414 1 to 783       783/783
(100 %)
0 diff
(100 %id)
BI554121 anaplastic oligodendroglioma with 1p/19qloss, brain .d 633 to 1339 1 to 707       707/707
(100 %)
5 diff
(99.3 %id)
CX868934 embryonic stem .d 634 to 1458 1 to 825       825/825
(100 %)
2 diff
(99.8 %id)
DR760610 embryonic stem .d 634 to 1299 1 to 666       666/666
(100 %)
0 diff
(100 %id)
CX784463 human embryonic stem cells .d 636 to 1296 1 to 661       661/661
(100 %)
0 diff
(100 %id)
CD579264 brain .d 638 to 1262 1 to 625       625/872
(71 %)
9 diff
(99.0 %id)
BE262318 brain, neuroblastoma .d 648 to 1346 1 to 695       695/737
(94 %)
14 diff
(98.2 %id)
BF026332 melanotic melanoma, skin .d 648 to 1385 1 to 738       738/738
(100 %)
3 diff
(99.6 %id)
BE260347 brain, neuroblastoma .d 650 to 1277 1 to 630       630/630
(100 %)
3 diff
(99.6 %id)
BE264946 lung, small cell carcinoma .d 650 to 1296 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BE903036 choriocarcinoma, placenta .d 651 to 1457 1 to 808       808/869
(92 %)
24 diff
(97.3 %id)
BE884362 leiomyosarcoma, uterus .d 652 to 1322 1 to 665       665/720
(92 %)
8 diff
(98.9 %id)
BE886873 leiomyosarcoma, uterus .d 655 to 1337 1 to 677       677/812
(83 %)
14 diff
(98.3 %id)
DN601576 human embryonic stem cells .d 663 to 1311 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
CN351592 embryonic stem cells, DMSO-treated H9 cellline .d 664 to 1257 1 to 594       594/594
(100 %)
0 diff
(100 %id)
CN351623 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 667 to 1295 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BG025379 lymph, lymphoma, cell line .d 668 to 1378 1 to 715       715/849
(84 %)
13 diff
(98.5 %id)
BE255204 eye, retinoblastoma .d 671 to 1303 1 to 633       633/633
(100 %)
2 diff
(99.7 %id)
CX167308 human embryonic stem cells differentiated toan early endodermal cell type .d 672 to 1415 1 to 744       744/744
(100 %)
1 diff
(99.9 %id)
CN351615 embryonic stem cells, DMSO-treated H9 cellline .d 674 to 1292 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BM471416 melanotic melanoma, skin .d 674 to 1641 11 to 977       967/995
(97 %)
28 diff
(97.2 %id)
BM466247 embryonal carcinoma, cell line, testis .d 679 to 1584 1 to 908       908/1113
(81 %)
22 diff
(98.1 %id)
CX786119 human embryonic stem cells .d 679 to 1391 1 to 713       713/713
(100 %)
0 diff
(100 %id)
BM476594 lymph, lymphoma, cell line .d 680 to 1611 1 to 948       948/1061
(89 %)
23 diff
(97.9 %id)
CX753111 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 684 to 1352 1 to 667     Submitted on the opposite strand 667/730
(91 %)
7 diff
(99.1 %id)
CX752086 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 695 to 1393 1 to 690     Submitted on the opposite strand 690/744
(92 %)
15 diff
(98.0 %id)
BE791205 lung, small cell carcinoma .d 697 to 1487 1 to 788       788/970
(81 %)
21 diff
(97.9 %id)
BG164554 hypernephroma, cell line, Kidney .d 701 to 1351 1 to 650       650/944
(68 %)
5 diff
(99.5 %id)
BM904581 leiomyosarcoma, uterus .d 703 to 1385 1 to 690       690/1201
(57 %)
20 diff
(98.4 %id)
BE791742 lung, small cell carcinoma .d 704 to 1500 1 to 802       780/967
(80 %)
16 diff
(98.4 %id)
BF036063 adenocarcinoma, ovary .d 710 to 1332 1 to 620       620/621
(99 %)
7 diff
(98.9 %id)
BG337638 leiomyosarcoma cell line, uterus .d 713 to 1310 1 to 600       600/837
(71 %)
5 diff
(99.5 %id)
BM423958 amelanotic melanoma, cell line, skin .d 718 to 1494 1 to 780       780/1006
(77 %)
12 diff
(98.9 %id)
BM808572 amelanotic melanoma, cell line, skin .d 719 to 1635 1 to 930       930/1096
(84 %)
19 diff
(98.3 %id)
CN351659 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 720 to 1299 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
CN351671 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 720 to 1296 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
BE794072 lung, small cell carcinoma .d 720 to 1487 1 to 766       766/803
(95 %)
16 diff
(98.1 %id)
BE791328 lung, small cell carcinoma .d 722 to 1542 1 to 818       818/1169
(69 %)
17 diff
(98.6 %id)
BI117458 lung, small cell carcinoma .d 743 to 1384 1 to 641       641/763
(84 %)
11 diff
(98.6 %id)
BU944637 adenocarcinoma, cell line, breast .d 750 to 1493 1 to 747       747/927
(80 %)
8 diff
(99.2 %id)
CN351596 embryonic stem cells, DMSO-treated H9 cellline .d 765 to 1061 1 to 297       297/297
(100 %)
0 diff
(100 %id)
BX447273 neuroblastoma .d 770 to 1790 1014 to 1   tiling clone,   1014/1021
(99 %)
28 diff
(97.3 %id)
BQ953472 sciatic nerve .d 777 to 1632 21 to 885       865/939
(92 %)
25 diff
(97.4 %id)
TI_1948244750   .d 782 to 1775 1129 to 139   tiling clone,   991/1241
(79 %)
35 diff
(97.2 %id)
BF745489 breast .d 785 to 1002 223 to 8     Submitted on the opposite strand 213/236
(90 %)
3 diff
(98.8 %id)
T32292 Kidney .d 792 to 1032 1 to 241     Submitted on the opposite strand 241/241
(100 %)
0 diff
(100 %id)
TI_59381981   .d 800 to 1493 104 to 798       690/734
(94 %)
33 diff
(95.6 %id)
BG480429 choriocarcinoma, placenta .d 802 to 1506 1 to 702       702/703
(99 %)
9 diff
(98.8 %id)
CN351610 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 814 to 1495 1 to 684       684/684
(100 %)
2 diff
(99.8 %id)
BQ882299 sympathetic trunk .d 817 to 1494 1 to 680       680/929
(73 %)
12 diff
(98.8 %id)
BI006610 kidney_tumor .d 820 to 965 1 to 146       146/146
(100 %)
5 diff
(96.6 %id)
T06961   .d 820 to 1245 1 to 426       426/426
(100 %)
0 diff
(100 %id)
BM799257 Ascites, stomach .d 821 to 1309 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BE298640 muscle, rhabdomyosarcoma .d 826 to 1403 1 to 579       579/624
(92 %)
13 diff
(98.0 %id)
BG025611 lymph, lymphoma, cell line .d 841 to 1487 1 to 648       648/990
(65 %)
11 diff
(98.9 %id)
CN351664 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 850 to 1474 6 to 632       627/632
(99 %)
4 diff
(99.4 %id)
BU152956 embryonal carcinoma, cell line, testis .d 852 to 1632 1 to 789       789/914
(86 %)
12 diff
(98.7 %id)
BQ054145 blood, natural killer cells, cell line .d 858 to 1713 1 to 877       877/1025
(85 %)
33 diff
(96.8 %id)
CN351676 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 861 to 1309 1 to 449       449/449
(100 %)
0 diff
(100 %id)
BM809487 amelanotic melanoma, cell line, skin .d 862 to 1765 27 to 948       920/1201
(76 %)
39 diff
(96.8 %id)
BG475395 melanotic melanoma, skin .d 871 to 1629 1 to 768       768/769
(99 %)
11 diff
(98.6 %id)
BG478316 melanotic melanoma, skin .d 871 to 1701 1 to 837       837/837
(100 %)
16 diff
(98.1 %id)
BI225323 Burkitt lymphoma, lymph .d 882 to 1516 1 to 637       637/639
(99 %)
12 diff
(98.2 %id)
CN351604 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 889 to 1574 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BE275348 melanotic melanoma, skin .d 890 to 1621 1 to 726       726/730
(99 %)
7 diff
(99.1 %id)
CX163561 human embryonic stem cells differentiated toan early endodermal cell type .e 1 to 701 7 to 708   tiling clone,   708/708
(100 %)
7 diff
(99.1 %id)
BU857474 adenocarcinoma, cell line, breast .e 674 to 1456 1 to 792   tiling clone,   792/903
(87 %)
15 diff
(98.4 %id)
BU956272 adenocarcinoma, cell line, breast .e 674 to 1455 1 to 787       787/928
(84 %)
18 diff
(98.1 %id)
CN351593 embryonic stem cells, cell lines H1, H7, andH9 .e 692 to 1204 13 to 525       513/525
(97 %)
0 diff
(100 %id)
CN351634 embryonic stem cells, cell lines H1, H7, andH9 .e 692 to 1345 21 to 674       654/674
(97 %)
0 diff
(100 %id)
CN351640 embryonic stem cells, cell lines H1, H7, andH9 .e 692 to 1219 20 to 547       528/547
(96 %)
1 diff
(99.9 %id)
CN351665 embryonic stem cells, cell lines H1, H7, andH9 .e 692 to 1382 27 to 718       692/718
(96 %)
1 diff
(99.9 %id)
CN351698 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 692 to 1306 29 to 643       615/643
(95 %)
1 diff
(99.9 %id)
BX420669 brain, fetal brain .e 692 to 1665 24 to 989   tiling clone,   966/1065
(90 %)
32 diff
(97.0 %id)
BX390572 Placenta Cot 25-normalized .e 692 to 1209 33 to 551       519/685
(75 %)
4 diff
(99.5 %id)
BE271251 Burkitt lymphoma, lymph .e 692 to 1493 71 to 871   tiling clone,   801/899
(89 %)
22 diff
(97.6 %id)
BE268261 Burkitt lymphoma, lymph .e 692 to 1414 64 to 782       719/815
(88 %)
19 diff
(97.7 %id)
BM012755 brain, neuroblastoma, cell line .e 692 to 1351 36 to 696       656/735
(89 %)
33 diff
(95.6 %id)
BM472037 melanotic melanoma, skin .e 692 to 1212 40 to 562       523/1190
(43 %)
5 diff
(99.6 %id)
BM802998 duodenal adenocarcinoma, cell line, small intestine .e 692 to 1458 98 to 866   tiling clone,   769/1081
(71 %)
9 diff
(99.2 %id)
BF036664 adenocarcinoma, ovary .e 693 to 1414 2 to 711       710/923
(76 %)
19 diff
(98.0 %id)
CR616248 T cells (Jurkat cell line) .f 1 to 1761 2 to 1762 exact tiling clone,   1762/1762
(100 %)
0 diff
(100 %id)
BX405295 T cells (Jurkat cell line) .f 1 to 887 2 to 885   fully sequenced,   885/885
(100 %)
9 diff
(99.0 %id)
CU449988 epidermis .f 335 to 963 654 to 28     Submitted on the opposite strand 627/654
(95 %)
7 diff
(99.0 %id)
BX405294 T cells (Jurkat cell line) .f 826 to 1761 933 to 1   fully sequenced,   933/933
(100 %)
8 diff
(99.2 %id)
TI_1948245014   .f 848 to 1726 1005 to 125       881/1354
(65 %)
25 diff
(98.2 %id)
AL518190 brain, neuroblastoma, neuroblastoma cells .f 849 to 1743 896 to 1       896/1128
(79 %)
25 diff
(97.8 %id)
TI_1948244486   .f 859 to 1709 990 to 140       851/1267
(67 %)
14 diff
(98.9 %id)
AW363739 colon .f 862 to 1009 147 to 1       147/163
(90 %)
3 diff
(98.2 %id)
NR_028388.2   .g 1 to 5084 1 to 5084 exact RefSeq, tiling clone,   5084/5084
(100 %)
0 diff
(100 %id)
AK130774 thymus .g 29 to 1815 1 to 1787 A145T available from FLJ,   1787/1787
(100 %)
6 diff
(99.7 %id)
BP328791 rectum .g 29 to 611 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DA051096   .g 30 to 626 2 to 598   capped   597/597
(100 %)
1 diff
(99.9 %id)
DA202258 brain .g 30 to 615 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
BP218715 caudate nucleus .g 30 to 612 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP232818 muscle .g 30 to 610 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CB988249 Human Placenta, placenta .g 30 to 765 28 to 766       739/767
(96 %)
24 diff
(96.9 %id)
BP270594 small intestine .g 30 to 611 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DC365464   .g 30 to 727 1 to 693       693/693
(100 %)
20 diff
(97.2 %id)
BP329394 rectum .g 30 to 613 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BM739689 Ascites, stomach .g 30 to 677 1 to 651       647/651
(99 %)
3 diff
(99.6 %id)
DA902376   .g 30 to 612 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA100668 cerebellum .g 31 to 619 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA200649 brain .g 31 to 614 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA205700 brain .g 31 to 630 2 to 601   capped   600/600
(100 %)
2 diff
(99.7 %id)
DA344434 substantia nigra .g 31 to 620 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA345908 substantia nigra .g 31 to 614 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA380896 thalamus .g 31 to 628 2 to 598   capped   597/597
(100 %)
3 diff
(99.5 %id)
DA678345   .g 31 to 761 2 to 738   capped   737/875
(84 %)
15 diff
(98.3 %id)
DA930230 small intestine .g 31 to 621 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
DB031691 testis .g 31 to 613 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DB192785 ovary, tumor tissue .g 31 to 612 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
BP287072 lung .g 32 to 616 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
DA345890 substantia nigra .g 33 to 616 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA648988   .g 33 to 617 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DB128341 thymus .g 33 to 616 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DB246680   .g 33 to 700 2 to 670   capped   669/672
(99 %)
8 diff
(98.9 %id)
BP279343   .g 34 to 615 1 to 582       582/583
(99 %)
4 diff
(99.4 %id)
BP346679 brain .g 34 to 616 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
DB027552 testis .g 35 to 642 2 to 609   capped   608/610
(99 %)
3 diff
(99.6 %id)
DB030739 testis .g 35 to 622 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB048786 testis .g 35 to 625 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
AU143423   .g 35 to 711 2 to 677   capped   676/676
(100 %)
3 diff
(99.6 %id)
BM556149 duodenal adenocarcinoma, cell line, small intestine .g 36 to 869 1 to 838       838/1036
(80 %)
19 diff
(98.2 %id)
CR975088 T-Lymphocytes .g 36 to 766 1 to 733       733/740
(99 %)
6 diff
(99.2 %id)
TI_1948244229   .g 38 to 868 207 to 1030       824/1167
(70 %)
21 diff
(98.3 %id)
TI_1948244485   .g 38 to 877 207 to 1047       841/1058
(79 %)
28 diff
(97.4 %id)
TI_1948244748   .g 38 to 868 205 to 1035       831/1249
(66 %)
25 diff
(98.0 %id)
TI_1948244749   .g 38 to 869 209 to 1040       832/1059
(78 %)
23 diff
(97.9 %id)
TI_1948245011   .g 38 to 860 205 to 1023       819/1214
(67 %)
17 diff
(98.6 %id)
TI_1948245012   .g 38 to 869 210 to 1036       827/1029
(80 %)
23 diff
(97.8 %id)
BX419628 brain, fetal brain .g 39 to 980 1 to 941       941/941
(100 %)
6 diff
(99.4 %id)
AL554132 placenta, Placenta Cot 25-normalized .g 39 to 851 1 to 811       811/811
(100 %)
20 diff
(97.6 %id)
CR990846 T-Lymphocytes .g 40 to 765 1 to 727       727/727
(100 %)
3 diff
(99.6 %id)
CR980640 T-Lymphocytes .g 40 to 716 1 to 679       679/685
(99 %)
6 diff
(99.2 %id)
CR987293 T-Lymphocytes .g 40 to 715 1 to 676       676/677
(99 %)
6 diff
(99.2 %id)
BU508939 leiomyosarcoma, uterus .g 41 to 851 1 to 816       816/868
(94 %)
27 diff
(96.9 %id)
BQ879053 dorsal root ganglia .g 42 to 807 1 to 771       771/856
(90 %)
16 diff
(98.2 %id)
CV808130 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 42 to 805 1 to 774       774/885
(87 %)
35 diff
(96.1 %id)
CV809379 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 42 to 766 1 to 725       725/726
(99 %)
5 diff
(99.4 %id)
CR983873 T-Lymphocytes .g 43 to 716 1 to 675       675/675
(100 %)
3 diff
(99.6 %id)
CR979612 T-Lymphocytes .g 43 to 829 1 to 787       787/790
(99 %)
7 diff
(99.2 %id)
CT002368 T-Lymphocytes .g 43 to 749 1 to 709       709/712
(99 %)
5 diff
(99.3 %id)
CR997693 T-Lymphocytes .g 43 to 869 1 to 828       828/872
(94 %)
4 diff
(99.6 %id)
CR975113 T-Lymphocytes .g 43 to 717 1 to 676       676/677
(99 %)
6 diff
(99.2 %id)
CR999417 T-Lymphocytes .g 43 to 772 1 to 732       732/733
(99 %)
5 diff
(99.4 %id)
CR999714 T-Lymphocytes .g 43 to 743 1 to 702       702/705
(99 %)
4 diff
(99.5 %id)
BM474452 leiomyosarcoma, uterus .g 44 to 877 1 to 840       838/981
(85 %)
27 diff
(97.3 %id)
BM552508 leiomyosarcoma, uterus .g 44 to 869 1 to 832       832/1045
(79 %)
21 diff
(98.0 %id)
BM474212 eye, retinoblastoma .g 44 to 877 1 to 838       838/1028
(81 %)
21 diff
(98.0 %id)
BX443069 B cells (Ramos cell line) .g 45 to 869 1 to 823       823/823
(100 %)
6 diff
(99.3 %id)
BQ049524 lymph, lymphoma, cell line .g 45 to 869 1 to 829       829/859
(96 %)
16 diff
(98.2 %id)
BQ881521 lymph, lymphoma, cell line .g 47 to 874 1 to 838       838/936
(89 %)
28 diff
(97.1 %id)
BG104942 adrenal cortex carcinoma, cell line, adrenal gland .g 49 to 795 1 to 747       747/774
(96 %)
18 diff
(97.7 %id)
BQ427499 eye, retinoblastoma .g 50 to 839 43 to 841       799/850
(94 %)
27 diff
(96.9 %id)
BG389368 embryonal carcinoma, cell line, testis .g 52 to 857 1 to 798       798/953
(83 %)
28 diff
(97.1 %id)
BE264440 lung, small cell carcinoma .g 57 to 582 1 to 526       526/526
(100 %)
0 diff
(100 %id)
BQ071528 brain, neuroblastoma, cell line .g 57 to 869 1 to 819       819/1051
(77 %)
31 diff
(97.1 %id)
BQ071764 brain, neuroblastoma, cell line .g 57 to 765 1 to 719       719/1129
(63 %)
21 diff
(98.2 %id)
BU553243 ovary, teratocarcinoma, cell line .g 57 to 831 1 to 779       779/882
(88 %)
7 diff
(99.3 %id)
BM557300 melanotic melanoma, skin .g 58 to 839 1 to 787       787/1071
(73 %)
29 diff
(97.3 %id)
BE396632 Burkitt lymphoma, lymph .g 61 to 741 1 to 681       681/685
(99 %)
6 diff
(99.2 %id)
BI113797 muscle, rhabdomyosarcoma .g 63 to 752 1 to 691       691/700
(98 %)
11 diff
(98.5 %id)
BI859378 breast, mammary adenocarcinoma, cell line .g 64 to 869 1 to 814       814/826
(98 %)
20 diff
(97.6 %id)
BQ421811 embryonal carcinoma, cell line, testis .g 64 to 869 1 to 809       809/853
(94 %)
22 diff
(97.5 %id)
BF530291 anaplastic oligodendroglioma with 1p/19qloss, brain .g 65 to 846 1 to 780       780/780
(100 %)
18 diff
(97.7 %id)
BM013593 breast, mammary adenocarcinoma, cell line .g 65 to 765 1 to 705       705/899
(78 %)
10 diff
(98.9 %id)
TI_59391496   .g 65 to 765 54 to 758       705/899
(78 %)
10 diff
(98.9 %id)
AW732556 Kidney, renal cell adenocarcinoma .g 67 to 628 1 to 562       562/562
(100 %)
6 diff
(99.0 %id)
BE795586 lung, small cell carcinoma .g 67 to 869 1 to 803       803/806
(99 %)
12 diff
(98.6 %id)
BG390818 embryonal carcinoma, cell line, testis .g 68 to 850 1 to 780       780/971
(80 %)
18 diff
(98.2 %id)
BE613463 leiomyosarcoma, uterus .g 69 to 759 1 to 689       689/732
(94 %)
5 diff
(99.4 %id)
CX752118 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 69 to 857 1 to 783     Submitted on the opposite strand 783/807
(97 %)
14 diff
(98.3 %id)
BE314249 brain, neuroblastoma .g 70 to 770 1 to 699       699/816
(85 %)
14 diff
(98.3 %id)
BE796030 lung, small cell carcinoma .g 70 to 868 1 to 798       798/840
(95 %)
10 diff
(98.9 %id)
BE884457 leiomyosarcoma, uterus .g 72 to 763 1 to 691       691/692
(99 %)
7 diff
(99.0 %id)
CX751091 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 73 to 857 1 to 779     Submitted on the opposite strand 779/813
(95 %)
10 diff
(98.8 %id)
BE559640 Burkitt lymphoma, lymph .g 129 to 869 1 to 749       749/1125
(66 %)
17 diff
(98.5 %id)
EH348457   .g 199 to 259 1 to 61       61/61
(100 %)
0 diff
(100 %id)
CA395489 eye, RPE/choroid .g 320 to 911 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
AA232601 brain, neuroepithelial cells .g 325 to 691 1 to 366       366/366
(100 %)
4 diff
(99.0 %id)
CV573829 cornea, eye .g 564 to 626 1 to 63       63/63
(100 %)
0 diff
(100 %id)
T07637   .g 621 to 835 1 to 215       215/215
(100 %)
0 diff
(100 %id)
DR155537 human embryonic stem cells differentiated toan early endodermal cell type .g 634 to 1288 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
BI255987 cervical carcinoma cell line, cervix .g 650 to 1464 1 to 812       814/814
(100 %)
14 diff
(98.3 %id)
BE878904 large cell carcinoma, undifferentiated, lung .g 664 to 1424 1 to 754       754/787
(95 %)
19 diff
(97.6 %id)
CT001019 T-Lymphocytes .g 875 to 1483 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BQ216384 embryonal carcinoma, cell line, testis .g 887 to 1611 1 to 734       734/890
(82 %)
14 diff
(98.5 %id)
BI914071 brain .g 890 to 1665 1 to 777       777/777
(100 %)
6 diff
(99.3 %id)
TI_57242699   .g 890 to 1665 36 to 812       777/812
(95 %)
6 diff
(99.3 %id)
BM802115 duodenal adenocarcinoma, cell line, small intestine .g 902 to 1617 1 to 721       721/1011
(71 %)
12 diff
(98.9 %id)
TI_1948245013   .g 902 to 1752 986 to 134   AAA   853/1256
(67 %)
17 diff
(98.7 %id)
BM823839 Ascites, stomach .g 908 to 1411 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BM853646 Ascites, stomach .g 926 to 1355 1 to 430       430/430
(100 %)
0 diff
(100 %id)
TI_1948244751   .g 927 to 1749 976 to 155       822/1380
(59 %)
23 diff
(98.4 %id)
BQ216051 large cell carcinoma, lung .g 929 to 1782 1 to 858       858/858
(100 %)
11 diff
(98.8 %id)
BF981489 duodenal adenocarcinoma, cell line, small intestine .g 937 to 1728 22 to 797       776/807
(96 %)
36 diff
(95.6 %id)
BI760131 pooled colon, kidney, stomach .g 948 to 1750 1 to 811       811/829
(97 %)
23 diff
(97.3 %id)
BE538765 cervix .g 962 to 1702 1 to 732       732/733
(99 %)
16 diff
(97.9 %id)
BF338929 brain, glioblastoma with EGFR amplification .g 982 to 1731 1 to 749       749/1041
(71 %)
8 diff
(99.3 %id)
AL576936 placenta, Placenta Cot 25-normalized .g 993 to 1761 771 to 1       772/832
(92 %)
31 diff
(96.3 %id)
BX352184 Placenta Cot 25-normalized .g 993 to 1810 812 to 1       812/884
(91 %)
26 diff
(97.1 %id)
TI_1948244232   .g 993 to 1749 908 to 153       756/1336
(56 %)
10 diff
(99.3 %id)
CB110587 Liver .g 994 to 1303 1 to 310       310/310
(100 %)
0 diff
(100 %id)
BI857503 breast, mammary adenocarcinoma, cell line .g 1001 to 1815 1 to 818   AAA   818/818
(100 %)
13 diff
(98.5 %id)
BG111397 Bone, osteosarcoma, cell line .g 1005 to 1749 1 to 746       746/1093
(68 %)
22 diff
(98.0 %id)
BM709456 eye, optic nerve .g 1007 to 1393 1 to 387   fully sequenced,   387/387
(100 %)
1 diff
(99.8 %id)
BM824813 Ascites, stomach .g 1013 to 1495 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BQ680131 melanotic melanoma, cell line, skin .g 1024 to 1753 1 to 737       737/926
(79 %)
23 diff
(97.6 %id)
BQ682195 melanotic melanoma, cell line, skin .g 1024 to 1742 1 to 725       725/922
(78 %)
33 diff
(96.5 %id)
BU541942 carcinoma, cell line, Prostate .g 1035 to 1723 1 to 695       695/1036
(67 %)
11 diff
(99.0 %id)
BG751308 eye, normal pigmented retinal epithelium .g 1037 to 1922 1 to 883       883/935
(94 %)
31 diff
(96.7 %id)
BM831889 stomach .g 1041 to 1593 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BC051293 Uterus, endometrium adenocarcinoma .g 1062 to 1815 1 to 754   available from MGC, AAA   754/754
(100 %)
0 diff
(100 %id)
BQ222973 large cell carcinoma, lung .g 1080 to 1815 1 to 738   AAA   738/738
(100 %)
6 diff
(99.2 %id)
T32204 skin .g 1081 to 1346 1 to 266       266/266
(100 %)
0 diff
(100 %id)
T32210 skin .g 1081 to 1270 1 to 190       190/190
(100 %)
0 diff
(100 %id)
BI258118 cervical carcinoma cell line, cervix .g 1089 to 1785 1 to 696       696/696
(100 %)
6 diff
(99.2 %id)
AA160721 Pancreas .g 1090 to 1494 1 to 401   fully sequenced,   401/401
(100 %)
2 diff
(99.6 %id)
BQ015147 Chondrosarcoma, Left Pubic Bone .g 1104 to 1815 731 to 19   AAA   713/713
(100 %)
1 diff
(99.9 %id)
EC517499 Prostate .g 1108 to 1215 1 to 108       108/108
(100 %)
0 diff
(100 %id)
CR985015 T-Lymphocytes .g 1109 to 1808 1 to 700       700/700
(100 %)
0 diff
(100 %id)
CN479878 Knee, Osteoarthritic Cartilage .g 1111 to 1815 723 to 19   AAA   705/706
(99 %)
2 diff
(99.8 %id)
BQ017805 Chondrosarcoma, Left Pubic Bone .g 1112 to 1815 723 to 19   AAA   705/705
(100 %)
4 diff
(99.5 %id)
BQ009995 Chondrosarcoma, Left Pubic Bone .g 1112 to 1815 723 to 19   AAA   705/705
(100 %)
1 diff
(99.9 %id)
CN351652 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 1118 to 1745 1 to 628       628/628
(100 %)
0 diff
(100 %id)
CT001716 T-Lymphocytes .g 1124 to 1698 1 to 575       575/579
(99 %)
1 diff
(99.9 %id)
TI_149278156   .g 1148 to 1811 747 to 83   AAA   665/667
(99 %)
1 diff
(99.9 %id)
BM463399 embryonal carcinoma, cell line, testis .g 1158 to 1815 1 to 658       658/658
(100 %)
0 diff
(100 %id)
BM760640 lymph node, stomach .g 1196 to 1493 1 to 298       298/298
(100 %)
0 diff
(100 %id)
BM760032 lymph node, stomach .g 1197 to 1584 1 to 388       388/388
(100 %)
0 diff
(100 %id)
BQ423580 embryonal carcinoma, cell line, testis .g 1208 to 1989 1 to 790       790/904
(87 %)
17 diff
(98.2 %id)
BU538492 adenocarcinoma, cell line, breast .g 1213 to 1815 1 to 603   AAA   603/603
(100 %)
0 diff
(100 %id)
BE207879 Kidney, renal cell adenocarcinoma .g 1260 to 1817 558 to 1       558/558
(100 %)
2 diff
(99.7 %id)
CN351649 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1287 to 1741 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BM709590 eye, optic nerve .g 1292 to 1815 1 to 524   fully sequenced, AAA   524/524
(100 %)
0 diff
(100 %id)
AA278178 germinal center B cell .g 1295 to 1489 1 to 195   fully sequenced,   195/195
(100 %)
0 diff
(100 %id)
DC426244   .g 1315 to 1815 502 to 1       502/502
(100 %)
5 diff
(99.1 %id)
BG060147 brain, glioblastoma without EGFR amplification .g 1316 to 1815 500 to 1       500/500
(100 %)
0 diff
(100 %id)
BG471794 eye, retinoblastoma .g 1330 to 1815 1 to 486   AAA   486/486
(100 %)
0 diff
(100 %id)
CN351603 embryonic stem cells, DMSO-treated H9 cellline .g 1331 to 1760 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BX117216 heart .g 1332 to 1815 1 to 484   AAA   484/484
(100 %)
0 diff
(100 %id)
BU733417 eye, optic nerve .g 1332 to 1815 503 to 19   fully sequenced, AAA   485/485
(100 %)
2 diff
(99.6 %id)
BM823701 Ascites, stomach .g 1334 to 1706 1 to 373       373/373
(100 %)
0 diff
(100 %id)
BM992893 lung, Metastatic Chondrosarcoma .g 1335 to 1815 499 to 19   AAA   481/481
(100 %)
0 diff
(100 %id)
AW516001 lymph node, lymphoma, follicular mixed small and largecell .g 1351 to 1815 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AW026653 brain, glioblastoma (pooled) .g 1363 to 1815 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AL552621 placenta, Placenta Cot 25-normalized .g 1366 to 1818 1 to 453   fully sequenced,   453/453
(100 %)
0 diff
(100 %id)
AW026686 brain, glioblastoma (pooled) .g 1368 to 1815 448 to 1       448/448
(100 %)
0 diff
(100 %id)
BM988843 lung, Lung Focal Fibrosis .g 1368 to 1815 466 to 19   AAA   448/448
(100 %)
0 diff
(100 %id)
AA356876   .g 1394 to 1662 1 to 269       269/269
(100 %)
0 diff
(100 %id)
AL134363 brain .g 1398 to 1815 1 to 418   AAA   418/418
(100 %)
0 diff
(100 %id)
BM150708 leukopheresis .g 1403 to 1815 433 to 20   AAA   414/414
(100 %)
10 diff
(97.6 %id)
BM692760 eye, Retina Foveal and Macular .g 1413 to 1802 1 to 390       390/390
(100 %)
0 diff
(100 %id)
BM716133 eye, Retina Foveal and Macular .g 1413 to 1815 1 to 403   AAA   403/403
(100 %)
0 diff
(100 %id)
AA232483 brain, neuroepithelial cells .g 1417 to 1818 404 to 3       402/404
(99 %)
1 diff
(99.8 %id)
AI498622 anaplastic oligodendroglioma, brain .g 1425 to 1815 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA279979 germinal center B cell .g 1430 to 1815 412 to 27   fully sequenced, AAA   386/386
(100 %)
1 diff
(99.8 %id)
AA159528 Pancreas .g 1433 to 1816 384 to 1   fully sequenced,   384/384
(100 %)
2 diff
(99.5 %id)
BU733602 eye, optic nerve .g 1433 to 1815 402 to 19   fully sequenced, AAA   384/384
(100 %)
1 diff
(99.8 %id)
AA416908   .g 1457 to 1803 1 to 345   fully sequenced,   345/345
(100 %)
2 diff
(99.5 %id)
BM874793   .g 1492 to 1815 1 to 324   AAA   324/324
(100 %)
0 diff
(100 %id)
CB134354 brain .g 1496 to 1815 1 to 320   AAA   320/320
(100 %)
0 diff
(100 %id)
BM704746 eye, RPE and Choroid .g 1502 to 2014 1 to 513   fully sequenced, Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
EC542302 Prostate .g 1539 to 1651 1 to 113       113/113
(100 %)
0 diff
(100 %id)
AA864200 Kidney, kidney tumor .g 1542 to 1816 275 to 1       275/275
(100 %)
0 diff
(100 %id)
AA988781 2 pooled tumors (clear cell type), Kidney .g 1544 to 1818 275 to 1       275/275
(100 %)
0 diff
(100 %id)
AW375885 colon .g 1559 to 1704 146 to 1       146/146
(100 %)
0 diff
(100 %id)
AW375889 colon .g 1559 to 1704 146 to 1       146/146
(100 %)
0 diff
(100 %id)
BU730076 eye, Retina Foveal and Macular .g 1562 to 1815 272 to 19   AAA   254/254
(100 %)
0 diff
(100 %id)
BU934991 mixed (pool of 40 RNAs) .g 1564 to 1815 1 to 252   AAA   252/252
(100 %)
0 diff
(100 %id)
CB987395 Pooled-Glandular .g 1564 to 1815 1 to 252   AAA   252/252
(100 %)
0 diff
(100 %id)
CK004609 brain/CNS, Human Brain - Frontal Cortex .g 1564 to 1815 1 to 252   AAA   252/252
(100 %)
0 diff
(100 %id)
BX644127   .g 1566 to 1815 1 to 250   AAA   250/250
(100 %)
0 diff
(100 %id)
BQ961516 leiomyosarcoma, uterus .g 1577 to 1815 1 to 239   AAA   239/239
(100 %)
0 diff
(100 %id)
AL552584 placenta, Placenta Cot 25-normalized .g 1581 to 1786 206 to 1   fully sequenced,   206/206
(100 %)
1 diff
(99.6 %id)
AA417009   .g 1581 to 1815 235 to 1   fully sequenced,   235/235
(100 %)
0 diff
(100 %id)
AI869494 anaplastic oligodendroglioma, brain .g 1582 to 1815 234 to 1       234/234
(100 %)
0 diff
(100 %id)
AA368847 placenta .g 1588 to 1816 1 to 229       229/229
(100 %)
0 diff
(100 %id)
AA315059 colon .g 1600 to 1815 1 to 216       216/216
(100 %)
0 diff
(100 %id)
DV459843 cochlea, ear .g 1601 to 1693 1 to 93       93/93
(100 %)
0 diff
(100 %id)
N66916 liver and spleen .g 1603 to 1815 233 to 21   AAA   213/213
(100 %)
0 diff
(100 %id)
BE673598 Prostate .g 1627 to 1816 190 to 1       190/190
(100 %)
0 diff
(100 %id)
AA383497 testis .g 1635 to 1815 1 to 181       181/181
(100 %)
0 diff
(100 %id)
CN351590 embryonic stem cells, DMSO-treated H9 cellline .g 1656 to 1815 1 to 160   AAA   160/160
(100 %)
0 diff
(100 %id)
AW072837 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .g 1705 to 1817 113 to 1       113/113
(100 %)
0 diff
(100 %id)
BQ439812 melanotic melanoma, skin .g 1732 to 1815 1 to 84   AAA   84/84
(100 %)
0 diff
(100 %id)
BY999799   .g 1735 to 1818 1 to 84     Submitted on the opposite strand 84/84
(100 %)
0 diff
(100 %id)
D20591   .g 1735 to 1810 1 to 76     Submitted on the opposite strand 76/84
(90 %)
1 diff
(98.9 %id)
BU730311 eye, RPE and Choroid .g 1798 to 2017 235 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
BQ671262 epidermoid carcinoma, cell line, salivary gland .g 2834 to 3723 1 to 895       895/914
(97 %)
26 diff
(97.2 %id)
BP364727 lung .h 1 to 577 1 to 577   tiling clone,   577/582
(99 %)
3 diff
(99.5 %id)
BP212329 cerebrum .h 2 to 586 1 to 584       584/584
(100 %)
10 diff
(98.3 %id)
BP212465 cerebrum .h 2 to 573 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BP216156 corpus callosum .h 2 to 577 1 to 574       574/581
(98 %)
4 diff
(99.4 %id)
DA476280   .h 2 to 572 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA628993 Kidney .h 2 to 577 2 to 577   capped   576/577
(99 %)
2 diff
(99.7 %id)
BP312913 mammary gland .h 2 to 577 1 to 575       575/583
(98 %)
3 diff
(99.5 %id)
DB016776 esophageal, tumor tissue .h 2 to 574 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA022049   .h 3 to 573 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA046362 bladder .h 3 to 577 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA061171 cerebellum .h 3 to 572 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA077249 cerebellum .h 3 to 574 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA127616 cerebellum .h 3 to 592 2 to 590   capped   589/593
(99 %)
8 diff
(98.7 %id)
DA194594 amygdala .h 3 to 592 2 to 591   capped   590/590
(100 %)
9 diff
(98.5 %id)
DA344006 substantia nigra .h 3 to 577 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA520103 brain .h 3 to 577 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA538295 Kidney .h 3 to 592 2 to 590   capped   589/593
(99 %)
8 diff
(98.7 %id)
DA541747 lung .h 3 to 592 2 to 590   tiling clone, capped   589/594
(99 %)
6 diff
(99.0 %id)
DA601071   .h 3 to 577 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA618531   .h 3 to 577 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA685512   .h 3 to 574 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA690901   .h 3 to 575 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA697635   .h 3 to 573 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA723868   .h 3 to 574 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
AU134198 ovary, tumor tissue .h 3 to 586 2 to 585   capped   584/595
(98 %)
8 diff
(98.7 %id)
DA902101   .h 3 to 573 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA982318 synovial membrane tissue from rheumatioidarthritis .h 3 to 575 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
DB054035 testis .h 3 to 572 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BP336820 coronary artery .h 4 to 601 1 to 600       600/607
(98 %)
12 diff
(98.1 %id)
DA031034   .h 5 to 574 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA170077 amygdala .h 5 to 572 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA380657 thalamus .h 5 to 573 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA382833 thalamus .h 5 to 592 2 to 589   capped   588/593
(99 %)
7 diff
(98.9 %id)
BE206799 lung, small cell carcinoma .h 6 to 577 1 to 572   fully sequenced,   572/572
(100 %)
6 diff
(99.0 %id)
BP331024 rectum .h 6 to 592 1 to 587       587/587
(100 %)
9 diff
(98.5 %id)
DA079665 cerebellum .h 7 to 577 2 to 572   capped   571/572
(99 %)
2 diff
(99.7 %id)
DA611536   .h 7 to 592 2 to 588   capped   587/593
(98 %)
8 diff
(98.7 %id)
DB008668 cervix, tumor tissue .h 7 to 574 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
CN351684 embryonic stem cells, cell lines H1, H7, andH9 .h 12 to 577 1 to 566       566/567
(99 %)
5 diff
(99.2 %id)
CR979027 T-Lymphocytes .h 12 to 590 1 to 579       579/588
(98 %)
7 diff
(98.9 %id)
CR997717 T-Lymphocytes .h 12 to 585 1 to 574       574/581
(98 %)
7 diff
(98.8 %id)
BM423374 amelanotic melanoma, cell line, skin .h 14 to 589 1 to 577       577/1145
(50 %)
8 diff
(99.4 %id)
CN288199 embryonic stem cells, DMSO-treated H9 cellline .h 15 to 720 1 to 707   tiling clone,   707/712
(99 %)
5 diff
(99.3 %id)
BQ688710 ductal carcinoma, cell line, Pancreas .h 15 to 592 1 to 578       578/1042
(55 %)
7 diff
(99.4 %id)
BU849668 ovary, teratocarcinoma, cell line .h 15 to 583 1 to 569       569/924
(61 %)
5 diff
(99.5 %id)
BU859630 ovary, teratocarcinoma, cell line .h 15 to 586 1 to 574       574/955
(60 %)
7 diff
(99.3 %id)
CR991830 T-Lymphocytes .h 15 to 592 1 to 578       578/579
(99 %)
8 diff
(98.7 %id)
CT003590 T-Lymphocytes .h 15 to 592 1 to 578       578/578
(100 %)
8 diff
(98.7 %id)
CR997130 T-Lymphocytes .h 15 to 592 1 to 578       578/578
(100 %)
8 diff
(98.7 %id)
CV575767 cornea, eye .h 17 to 575 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
CR985146 T-Lymphocytes .h 17 to 577 1 to 561       561/570
(98 %)
2 diff
(99.7 %id)
CN351646 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 18 to 577 1 to 560       560/561
(99 %)
3 diff
(99.5 %id)
DA112459 cerebellum .h 19 to 574 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
CR991572 T-Lymphocytes .h 20 to 592 1 to 573       573/580
(98 %)
8 diff
(98.7 %id)
BE336810 Kidney, renal cell adenocarcinoma .h 21 to 586 1 to 566       566/570
(99 %)
6 diff
(99.0 %id)
CR978683 T-Lymphocytes .h 21 to 592 1 to 572       572/581
(98 %)
8 diff
(98.7 %id)
DA075933 cerebellum .h 22 to 575 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
CN351630 embryonic stem cells, cell lines H1, H7, andH9 .h 22 to 576 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
CT002692 T-Lymphocytes .h 24 to 586 1 to 563       563/563
(100 %)
7 diff
(98.8 %id)
CR975187 T-Lymphocytes .h 24 to 591 1 to 569       569/581
(97 %)
11 diff
(98.2 %id)
CT001897 T-Lymphocytes .h 29 to 585 1 to 557       557/559
(99 %)
6 diff
(99.0 %id)
CR979409 T-Lymphocytes .h 30 to 592 1 to 563       563/563
(100 %)
7 diff
(98.8 %id)
DA056235 cerebellum .h 36 to 589 2 to 555   capped   554/562
(98 %)
7 diff
(98.8 %id)
CR983308 T-Lymphocytes .h 36 to 585 1 to 550       550/551
(99 %)
6 diff
(99.0 %id)
BP382785 adipose tissue .h 39 to 590 1 to 552       552/559
(98 %)
10 diff
(98.3 %id)
BU159866 eye, retinoblastoma .h 39 to 583 1 to 545       545/951
(57 %)
4 diff
(99.6 %id)
BM475736 embryonal carcinoma, cell line, testis .h 46 to 592 1 to 547       547/1094
(50 %)
6 diff
(99.5 %id)
DA246825 brain .h 48 to 585 2 to 538   capped   537/541
(99 %)
8 diff
(98.6 %id)
DB052197 testis .h 69 to 592 2 to 526   capped   525/533
(98 %)
7 diff
(98.7 %id)
S75763   .h 330 to 604 1 to 275       275/377
(72 %)
10 diff
(97.4 %id)
AW731938 lung, small cell carcinoma .h 562 to 1123 567 to 6   tiling clone, fully sequenced,   562/567
(99 %)
9 diff
(98.5 %id)
AU155291 ovary, tumor tissue .h 636 to 1120 486 to 1       486/546
(89 %)
6 diff
(99.0 %id)
BE206200 Kidney, renal cell adenocarcinoma .h 643 to 1123 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BE742270 adenocarcinoma cell line, ovary .i 1 to 793 1 to 792 R205E N206E E207* tiling clone,   792/942
(84 %)
16 diff
(98.4 %id)
BG257180 embryonal carcinoma, cell line, testis .j -9 to 712 1 to 744   tiling clone,   744/985
(75 %)
44 diff
(95.6 %id)
TI_159694657   .j 336 to 1007 785 to 114   tiling clone, AAA   672/934
(71 %)
14 diff
(98.6 %id)
BM995318 Chondrosarcoma, Left Pubic Bone .j 662 to 1007 364 to 19   tiling clone, AAA   346/488
(70 %)
0 diff
(100 %id)
DW428982 Liver .j 759 to 1007 15 to 263   AAA   249/263
(94 %)
6 diff
(97.8 %id)
DW433558 Liver .j 759 to 1005 15 to 261       247/262
(94 %)
2 diff
(99.3 %id)
AA515194 alveolar rhabdomyosarcoma .j 785 to 951 1 to 167       167/167
(100 %)
0 diff
(100 %id)
BE765021 nervous_tumor .j 811 to 988 179 to 2       178/186
(95 %)
0 diff
(100 %id)
BE773469 prostate_tumor .k 1 to 243 1 to 243   tiling clone,   243/243
(100 %)
5 diff
(98.0 %id)
AW801470 uterus .k 18 to 435 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
AW801623 uterus .k 63 to 435 373 to 1   tiling clone,   373/381
(97 %)
4 diff
(99.0 %id)
TI_154102174   .k 173 to 934 833 to 78   tiling clone, AAA   756/940
(80 %)
9 diff
(99.1 %id)
AU133868 ovary, tumor tissue .l 1 to 608 2 to 609   tiling clone, capped   608/608
(100 %)
3 diff
(99.6 %id)
AB208902 brain .l 11 to 4930 1 to 4920   tiling clone,   4920/4920
(100 %)
3 diff
(100.0 %id)
CA394992 eye, RPE/choroid .l 603 to 1102 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
BX456667 thymus .l 613 to 1499 1 to 892       892/956
(93 %)
15 diff
(98.5 %id)
CN288209 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 617 to 1086 1 to 470       470/470
(100 %)
0 diff
(100 %id)
CN288197 embryonic stem cells, cell lines H1, H7, andH9 .l 619 to 1079 1 to 461       461/461
(100 %)
0 diff
(100 %id)
DC325485 brain .l 631 to 1205 1 to 580       580/580
(100 %)
6 diff
(99.0 %id)
CN288207 embryonic stem cells, cell lines H1, H7, andH9 .l 674 to 1310 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BG427441 Kidney .l 822 to 1616 1 to 796       796/805
(98 %)
19 diff
(97.7 %id)
CN288195 embryonic stem cells, cell lines H1, H7, andH9 .l 869 to 1501 1 to 633       633/633
(100 %)
0 diff
(100 %id)
CN288201 embryonic stem cells, DMSO-treated H9 cellline .l 891 to 1400 1 to 510       510/510
(100 %)
0 diff
(100 %id)
TI_149306128   .l 972 to 1748 64 to 838     Submitted on the opposite strand 775/1046
(74 %)
10 diff
(99.1 %id)
CB851203 lung, Primary Lung Epithelial Cells .l 972 to 1719 9 to 756     Submitted on the opposite strand 748/756
(98 %)
6 diff
(99.3 %id)
CN288196 embryonic stem cells, cell lines H1, H7, andH9 .l 979 to 1242 1 to 264       264/264
(100 %)
0 diff
(100 %id)
BF108540 carcinoid, lung .l 1013 to 1432 1 to 420     Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
BF448249 carcinoid, lung .l 1144 to 1731 588 to 1       588/588
(100 %)
0 diff
(100 %id)
AU155041 ovary, tumor tissue .l 1225 to 1784 562 to 1       562/565
(99 %)
9 diff
(98.5 %id)
DB095192 testis .l 1264 to 1858 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
FN119662 breast carcinoma .l 1299 to 1400 1 to 101       101/101
(100 %)
4 diff
(96.1 %id)
AI131076 heart .l 1307 to 1728 422 to 1       422/422
(100 %)
0 diff
(100 %id)
CN288212 embryonic stem cells, cell lines H1, H7, andH9 .l 1328 to 1748 1 to 421       421/421
(100 %)
0 diff
(100 %id)
AI074537 B-cell, chronic lymphotic leukemia .l 1393 to 1744 352 to 1       352/352
(100 %)
0 diff
(100 %id)
DA312122 hippocampus .l 1418 to 1959 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
AA279578 germinal center B cell .l 1447 to 1707 261 to 1     Submitted on the opposite strand 261/261
(100 %)
0 diff
(100 %id)
DA415187 thalamus .l 1472 to 1998 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA113770 cerebellum .l 1566 to 2106 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BF222952 pooled germ cell tumors .l 1574 to 2154 581 to 1       581/581
(100 %)
0 diff
(100 %id)
CX756138 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .l 1593 to 2314 1 to 715     Submitted on the opposite strand 715/848
(84 %)
12 diff
(98.6 %id)
TI_44384963   .l 1625 to 2280 162 to 819   AAA   658/1131
(58 %)
26 diff
(97.8 %id)
TI_154162082   .l 1735 to 2220 69 to 557       489/584
(83 %)
23 diff
(96.1 %id)
DB148397 thymus .l 1739 to 2213 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
DA196761 amygdala .l 1751 to 2314 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA845254 placenta .l 1759 to 2314 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CN288208 embryonic stem cells, cell lines H1, H7, andH9 .l 1764 to 2450 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
BE816671 breast_normal .l 1837 to 1980 144 to 1       144/144
(100 %)
0 diff
(100 %id)
DB145744 thymus .l 1859 to 2397 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AA723724 pooled .l 1902 to 2153 252 to 1       252/252
(100 %)
0 diff
(100 %id)
CN288193 embryonic stem cells, cell lines H1, H7, andH9 .l 1979 to 2566 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BF759367 colon .l 2075 to 2309 15 to 241       227/241
(94 %)
6 diff
(97.6 %id)
DB026278 testis .l 2167 to 2718 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AA281539 germinal center B cell .l 2210 to 2367 1 to 158     Submitted on the opposite strand 158/158
(100 %)
0 diff
(100 %id)
DA778920 brain .l 2250 to 2804 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA495252 brain .l 2335 to 2908 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB285313 uterus .l 2396 to 2947 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BX644897   .l 2559 to 3198 1 to 640       640/640
(100 %)
0 diff
(100 %id)
DA177105 amygdala .l 2581 to 3023 2 to 444   capped   443/443
(100 %)
0 diff
(100 %id)
DB017314 esophageal, tumor tissue .l 2586 to 3129 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BQ716362 sympathetic trunk .l 2776 to 3589 1 to 826       826/902
(91 %)
19 diff
(97.9 %id)
DA180793 amygdala .l 2794 to 3349 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CN291315 embryonic stem cells, DMSO-treated H9 cellline .l 2859 to 2996 1 to 138       138/138
(100 %)
0 diff
(100 %id)
BX424394 thymus .l 2987 to 3826 1 to 840       840/840
(100 %)
21 diff
(97.5 %id)
CN351653 embryonic stem cells, cell lines H1, H7, andH9 .l 3044 to 3457 1 to 414       414/414
(100 %)
0 diff
(100 %id)
AL602934 human skeletal muscle .l 3362 to 4031 1 to 671       671/671
(100 %)
4 diff
(99.5 %id)
CN351616 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 3510 to 4250 1 to 739       739/739
(100 %)
5 diff
(99.4 %id)
CN351601 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 3525 to 4242 1 to 720       720/720
(100 %)
3 diff
(99.6 %id)
CN351692 embryonic stem cells, cell lines H1, H7, andH9 .l 3668 to 4363 1 to 696       696/696
(100 %)
6 diff
(99.2 %id)
AA934079 carcinoid, lung .l 3960 to 4184 1 to 225     Submitted on the opposite strand 225/225
(100 %)
0 diff
(100 %id)
BU752280 placenta .l 3960 to 4404 10 to 454     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
BF445014 carcinoid, lung .l 3976 to 4331 1 to 356     Submitted on the opposite strand 356/356
(100 %)
0 diff
(100 %id)
BX456666 thymus .l 4442 to 4900 464 to 1       464/464
(100 %)
9 diff
(98.1 %id)
BU509588 leiomyosarcoma, uterus .m 1 to 691 31 to 730 K192* tiling clone,   700/910
(76 %)
20 diff
(97.9 %id)
DB062356 testis .n-u 1 to 528 2 to 529   tiling clone, capped   528/528
(100 %)
0 diff
(100 %id)
BX956181   .n-u 488 to 960 1 to 474   tiling clone,   474/474
(100 %)
2 diff
(99.6 %id)
BF882209 lung_tumor .n-u 500 to 848 347 to 1     Submitted on the opposite strand 347/347
(100 %)
2 diff
(99.5 %id)
CN412609 embryonic stem cells, cell lines H1, H7, andH9 .n-u 618 to 1197 1 to 578   tiling clone,   578/578
(100 %)
2 diff
(99.7 %id)
DA692156   .o 1 to 571 2 to 573   tiling clone, capped   572/572
(100 %)
4 diff
(99.4 %id)
DA084059 cerebellum .o 3 to 570 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
BP244599 Kidney .o 3 to 590 1 to 588   tiling clone,   588/593
(99 %)
8 diff
(98.7 %id)
BP252615 Kidney .o 3 to 583 1 to 581       581/583
(99 %)
5 diff
(99.2 %id)
DA920695 small intestine .o 3 to 572 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA001689   .o 4 to 571 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA180756 amygdala .o 4 to 572 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA213007 brain .o 4 to 575 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA384595 thalamus .o 4 to 596 2 to 594   capped   593/595
(99 %)
10 diff
(98.4 %id)
DA482313   .o 4 to 583 2 to 580   capped   579/586
(98 %)
9 diff
(98.5 %id)
DA541201 lung .o 4 to 587 2 to 585   capped   584/584
(100 %)
7 diff
(98.9 %id)
DA562108 heart .o 4 to 571 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA879774 Prostate .o 4 to 570 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA902323   .o 4 to 574 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA907421   .o 4 to 573 2 to 572   capped   571/571
(100 %)
4 diff
(99.3 %id)
DA976865 synovial membrane tissue from rheumatioidarthritis .o 4 to 575 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA998283   .o 4 to 572 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DB012952 esophageal, tumor tissue .o 4 to 575 2 to 573   capped   572/573
(99 %)
2 diff
(99.7 %id)
DB022574 testis .o 4 to 571 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DB050587 testis .o 4 to 570 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA651965   .o 6 to 575 2 to 572   tiling clone, capped   571/571
(100 %)
2 diff
(99.7 %id)
DB244820 uterus, tumor tissue .o 6 to 571 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA541290 lung .o 8 to 584 2 to 578   capped   577/589
(97 %)
8 diff
(98.7 %id)
CN351660 embryonic stem cells, cell lines H1, H7, andH9 .o 11 to 590 1 to 580       580/587
(98 %)
9 diff
(98.5 %id)
CR978724 T-Lymphocytes .o 13 to 575 1 to 563       563/574
(98 %)
2 diff
(99.7 %id)
CR986568 T-Lymphocytes .o 16 to 599 1 to 585       585/599
(97 %)
11 diff
(98.2 %id)
CR989423 T-Lymphocytes .o 16 to 590 1 to 576       576/577
(99 %)
8 diff
(98.7 %id)
BM469428 lymph, lymphoma, cell line .o 17 to 589 1 to 574   tiling clone,   574/578
(99 %)
9 diff
(98.5 %id)
CR988414 T-Lymphocytes .o 19 to 590 10 to 581       572/615
(93 %)
10 diff
(98.4 %id)
CT000863 T-Lymphocytes .o 21 to 600 1 to 578 S167G G169E G171E G173W G174X     578/605
(95 %)
14 diff
(97.7 %id)
CN351638 embryonic stem cells, DMSO-treated H9 cellline .o 22 to 590 1 to 569       569/573
(99 %)
7 diff
(98.8 %id)
CR997313 T-Lymphocytes .o 22 to 589 1 to 569   tiling clone,   569/569
(100 %)
7 diff
(98.8 %id)
CN288194 embryonic stem cells, cell lines H1, H7, andH9 .o 35 to 599 25 to 590       566/593
(95 %)
15 diff
(97.5 %id)
BQ068845 brain, neuroblastoma, cell line .o 36 to 581 1 to 546       546/979
(55 %)
5 diff
(99.5 %id)
BU856305 ovary, teratocarcinoma, cell line .o 39 to 584 1 to 546       546/1021
(53 %)
4 diff
(99.7 %id)
CN351674 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .p 1 to 497 1 to 498 S55* tiling clone,   498/498
(100 %)
4 diff
(99.2 %id)
TI_159723365   .q 1 to 636 716 to 80 exact AAA   637/982
(64 %)
2 diff
(99.8 %id)
CA945027 Human Lung Epithelial cells, lung .q 1 to 636 655 to 19 exact tiling clone, AAA   637/645
(98 %)
2 diff
(99.7 %id)
H42562 breast .r-u 1 to 394 49 to 440   tiling clone, fully sequenced,   393/440
(89 %)
6 diff
(98.7 %id)
BF083928 colon .r-u 10 to 318 1 to 309   tiling clone,   309/317
(97 %)
6 diff
(98.2 %id)
BF086042 placenta_normal .r-u 10 to 297 305 to 19   tiling clone,   287/311
(92 %)
0 diff
(100 %id)
BE930017 placenta_normal .r-u 11 to 318 323 to 7       317/330
(96 %)
0 diff
(100 %id)
BG001856 placenta_normal .r-u 11 to 316 313 to 7       307/320
(95 %)
0 diff
(100 %id)
H43040 breast .r-u 368 to 871 511 to 5   tiling clone, fully sequenced,   507/511
(99 %)
16 diff
(96.9 %id)
AJ549096 low grade fibromyxoid sarcoma .s 34 to 370 142 to 478 exact tiling clone,   383/478
(80 %)
6 diff
(98.8 %id)
BP222919   .t 1 to 583 1 to 582   tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
AK301110 Spleen .t 2 to 953 1 to 951 N115S tiling clone,   951/951
(100 %)
4 diff
(99.6 %id)
DC315610 amygdala .t 2 to 530 1 to 530 Y25L S26F Q27P Q28A S29E ...     530/530
(100 %)
2 diff
(99.7 %id)
DC320217 brain .t 2 to 568 1 to 567 Y55*     567/567
(100 %)
2 diff
(99.7 %id)
DC379261 pericardium .t 2 to 551 1 to 552       552/552
(100 %)
3 diff
(99.5 %id)
DC389825 Spleen .t 2 to 594 1 to 593 N115S     593/593
(100 %)
2 diff
(99.7 %id)
DC407602 thymus .t 2 to 502 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
DC356097   .t 4 to 551 1 to 548   tiling clone,   548/548
(100 %)
1 diff
(99.9 %id)
BP356493 mammary gland .t 4 to 585 1 to 582 Q36H A69V V85A S100R     582/582
(100 %)
15 diff
(97.5 %id)
DC388943 Spleen .t 6 to 551 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
BX093525 liver and spleen .t 11 to 565 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
T88762 liver and spleen .t 12 to 424 1 to 424       424/433
(97 %)
31 diff
(92.9 %id)
R07006 liver and spleen .t 12 to 338 1 to 332   tiling clone,   332/337
(98 %)
16 diff
(95.3 %id)
AA004532 liver and spleen .t 12 to 265 1 to 258       259/258
(100 %)
19 diff
(92.7 %id)
AA299628 uterus .t 13 to 354 1 to 340       340/340
(100 %)
9 diff
(97.4 %id)
T77137 liver and spleen .t 13 to 400 1 to 395       395/450
(87 %)
27 diff
(94.0 %id)
AA299629 uterus .t 51 to 410 362 to 1       362/362
(100 %)
4 diff
(98.9 %id)
T99291 liver and spleen .t 85 to 372 1 to 301       301/306
(98 %)
21 diff
(93.2 %id)
BF089252 head_neck .t 100 to 307 207 to 1       207/212
(97 %)
6 diff
(97.2 %id)
BF833545 head_neck .t 111 to 320 228 to 19     Submitted on the opposite strand 210/246
(85 %)
12 diff
(95.2 %id)
BF738552 bladder_tumor .t 114 to 400 287 to 3     Submitted on the opposite strand 285/294
(96 %)
0 diff
(100 %id)
BQ379301 uterus_tumor .t 114 to 309 198 to 5       194/218
(88 %)
0 diff
(100 %id)
N74628 liver and spleen .t 424 to 883 466 to 1       466/486
(95 %)
6 diff
(98.8 %id)
AA004533 liver and spleen .t 453 to 868 425 to 7       419/425
(98 %)
0 diff
(100 %id)
T76972 liver and spleen .t 475 to 882 421 to 1       421/425
(99 %)
19 diff
(95.6 %id)
AI655141 pooled germ cell tumors .t 482 to 892 411 to 1   tiling clone,   411/411
(100 %)
0 diff
(100 %id)
BE502535 pooled germ cell tumors .t 506 to 882 420 to 44   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 377/377
(100 %)
2 diff
(99.5 %id)
R07007 liver and spleen .t 517 to 870 365 to 1       365/365
(100 %)
18 diff
(95.1 %id)
BE676466 B-cell, chronic lymphotic leukemia .t 531 to 882 394 to 43   AAA Possibly primed on the genome, locally A rich (22/24 A in genome downstream of last aligned base) 352/408
(86 %)
4 diff
(99.1 %id)
BE676638 B-cell, chronic lymphotic leukemia .t 531 to 882 352 to 1       352/468
(75 %)
0 diff
(100 %id)
DA071107 cerebellum .u 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BY795898 eye .u 53 to 681 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BG674310 skin .u 113 to 902 1 to 787       787/949
(82 %)
16 diff
(98.4 %id)
CR990692 T-Lymphocytes .u 391 to 1067 1 to 677   tiling clone,   677/681
(99 %)
2 diff
(99.8 %id)
DB154252 thymus .u 483 to 1071 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
AW603965 colon .u 715 to 1355 1 to 641       641/641
(100 %)
5 diff
(99.3 %id)
AW604087 colon .u 715 to 1246 1 to 531       531/531
(100 %)
3 diff
(99.5 %id)
AW847875 colon .u 715 to 1165 1 to 451       451/451
(100 %)
2 diff
(99.6 %id)
AA779569   .u 909 to 1201 1 to 289   AAA Submitted on the opposite strand 289/289
(100 %)
7 diff
(97.6 %id)
AI914269 carcinoid, lung .u 917 to 1391 1 to 475   tiling clone, Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
BE142881 head_neck .u 1098 to 1461 1 to 365       365/365
(100 %)
2 diff
(99.5 %id)
AW604126 colon .u 1116 to 1754 639 to 1   tiling clone,   639/640
(99 %)
0 diff
(100 %id)
AW604127 colon .u 1116 to 1755 642 to 2       641/644
(99 %)
0 diff
(100 %id)
BG991020 head_neck .u 1226 to 1548 323 to 3       321/330
(97 %)
0 diff
(100 %id)
BF741237 bocio_tumor .u 1228 to 1552 8 to 339       332/339
(97 %)
6 diff
(98.3 %id)
AW847758 colon .u 1236 to 1754 519 to 1       519/519
(100 %)
0 diff
(100 %id)
AW390154 stomach .u 1253 to 1844 6 to 596       591/610
(96 %)
6 diff
(99.1 %id)
BE142795 head_neck .u 1362 to 1751 401 to 3     Submitted on the opposite strand 399/471
(84 %)
0 diff
(100 %id)
AW847710 colon .u 1401 to 1754 353 to 1       353/353
(100 %)
6 diff
(98.4 %id)
AI151164 uterus .u 1401 to 1844 444 to 1       444/444
(100 %)
0 diff
(100 %id)
BG401770 Kidney .u 1543 to 2230 1 to 681   tiling clone,   681/845
(80 %)
18 diff
(97.9 %id)
BF906187 marrow .u 1591 to 2036 19 to 463       445/463
(96 %)
6 diff
(98.8 %id)
AI298382 carcinoid, lung .u 1626 to 2061 1 to 436     Submitted on the opposite strand 436/436
(100 %)
1 diff
(99.8 %id)
AW877532 pnet .u 1813 to 2134 5 to 324   tiling clone,   320/324
(98 %)
6 diff
(98.2 %id)
AW936027 denis_drash .u 1815 to 2141 339 to 13     Submitted on the opposite strand 327/341
(95 %)
0 diff
(100 %id)
BE069034 breast .u 1815 to 2154 344 to 6     Submitted on the opposite strand 339/352
(96 %)
0 diff
(100 %id)
AW935782 denis_drash .u 1820 to 2153 18 to 349       332/350
(94 %)
15 diff
(95.8 %id)
AW877455 pnet .u 1824 to 2129 315 to 7       309/316
(97 %)
0 diff
(100 %id)
AW835623 leiomios .u 1826 to 2123 296 to 1       296/296
(100 %)
16 diff
(94.6 %id)
AW835780 leiomios .u 1826 to 2148 327 to 6       322/327
(98 %)
0 diff
(100 %id)
AW877463 pnet .u 1826 to 2129 309 to 5       305/309
(98 %)
0 diff
(100 %id)
AW935869 denis_drash .u 1826 to 2101 282 to 11     Submitted on the opposite strand 272/282
(96 %)
6 diff
(97.9 %id)
CV318569 head_neck .u 1838 to 1952 1 to 114       114/129
(88 %)
14 diff
(89.2 %id)
AW877525 pnet .u 1844 to 2134 1 to 292       292/292
(100 %)
8 diff
(97.3 %id)
AW877519 pnet .u 1899 to 2134 1 to 243       243/243
(100 %)
14 diff
(94.3 %id)
BF362761 nervous_normal .u 2018 to 2260 13 to 252       240/261
(91 %)
6 diff
(97.8 %id)
AW898641 nervous_normal .u 2019 to 2246 229 to 1       229/229
(100 %)
4 diff
(98.3 %id)
BF955968 nervous_normal .u 2019 to 2260 246 to 4       243/246
(98 %)
0 diff
(100 %id)
BF955970 nervous_normal .u 2019 to 2238 222 to 5       218/222
(98 %)
0 diff
(100 %id)
BF362776 nervous_normal .u 2020 to 2260 1 to 241       241/250
(96 %)
2 diff
(99.2 %id)
DA682538 ovary .u 2057 to 2618 2 to 563 exact tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
BF361668 nervous_normal .u 2166 to 2328 174 to 13       162/174
(93 %)
0 diff
(100 %id)
CV319075 nervous_normal .u 2166 to 2328 174 to 13     Submitted on the opposite strand 162/174
(93 %)
0 diff
(100 %id)
BG420150 Kidney, renal cell adenocarcinoma .va 1 to 758 1 to 752 I7M K9S C10A P12L L13S ... tiling clone,   752/878
(85 %)
29 diff
(96.7 %id)
T08713   .va 378 to 798 1 to 427   tiling clone,   427/430
(99 %)
9 diff
(98.0 %id)
BM009272 amelanotic melanoma, cell line, skin .va 805 to 1377 1 to 591   tiling clone,   591/1030
(57 %)
67 diff
(93.5 %id)
TI_59383998   .va 806 to 1377 97 to 686       590/1029
(57 %)
66 diff
(93.6 %id)
N45730 multiple sclerosis lesions .va 907 to 1021 1 to 114       114/124
(91 %)
2 diff
(98.4 %id)
AA447875 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 1193 to 1562 1 to 371   tiling clone,   371/371
(100 %)
2 diff
(99.5 %id)
AA340825 Kidney .va 1402 to 1605 1 to 205   tiling clone,   205/205
(100 %)
1 diff
(99.6 %id)
H95561 liver and spleen .va 1469 to 1813 347 to 1   tiling clone,   347/351
(98 %)
4 diff
(98.9 %id)
AI358736 lymph node, lymphoma, follicular mixed small and largecell .va 1695 to 2090 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
AI333366 lung .va 1702 to 2090 390 to 2   tiling clone,   389/390
(99 %)
0 diff
(100 %id)
N49102 multiple sclerosis lesions .va 1719 to 2074 358 to 1       358/358
(100 %)
4 diff
(98.9 %id)
AA447717.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 1781 to 2046 266 to 1     also hits gene PRKAA1 266/266
(100 %)
0 diff
(100 %id)
DW442850 Liver .va 1782 to 1998 17 to 233       217/233
(93 %)
6 diff
(97.5 %id)
AW938121 denis_drash .vb 1 to 513 1 to 515   tiling clone,   515/515
(100 %)
27 diff
(94.8 %id)
AW364886 denis_drash .vb 11 to 477 20 to 491   tiling clone,   472/491
(96 %)
6 diff
(98.8 %id)
BG925327 cartilage .vb 197 to 821 94 to 718   tiling clone,   625/649
(96 %)
6 diff
(99.1 %id)
EH351767   .vb 389 to 455 1 to 67       67/67
(100 %)
0 diff
(100 %id)
BX456444 thymus .vb 554 to 1331 779 to 1 K13I A14G K16*     779/779
(100 %)
19 diff
(97.6 %id)
BU616526 Bone, Subchondral Bone .vb 603 to 1375 791 to 19 exact AAA   773/773
(100 %)
2 diff
(99.8 %id)
AA001333 liver and spleen .vb 634 to 1004 1 to 372   fully sequenced,   372/372
(100 %)
1 diff
(99.8 %id)
AA001279 liver and spleen .vb 634 to 1004 1 to 372   fully sequenced,   372/372
(100 %)
1 diff
(99.8 %id)
BQ446807 Knee, Osteoarthritic Cartilage .vb 670 to 1375 723 to 19 exact tiling clone, AAA   705/705
(100 %)
1 diff
(99.9 %id)
BU616514 Bone, Subchondral Bone .vb 789 to 1375 606 to 19 P15R AAA   588/588
(100 %)
5 diff
(99.2 %id)
AI921382 adenocarcinoma, Pancreas .vb 859 to 1378 520 to 1 exact tiling clone,   520/520
(100 %)
0 diff
(100 %id)
AA001940 liver and spleen .vb 974 to 1375 403 to 1   fully sequenced,   403/403
(100 %)
1 diff
(99.8 %id)
AA001956 liver and spleen .vb 974 to 1375 404 to 1   fully sequenced,   404/404
(100 %)
2 diff
(99.6 %id)
BG998514 head_neck .vc 1 to 497 518 to 20 K5N I17D T18L G19Q V20A ... tiling clone,   498/518
(96 %)
6 diff
(98.9 %id)
BE763523 nervous_tumor .vc 208 to 466 259 to 1   tiling clone,   259/259
(100 %)
1 diff
(99.7 %id)
AA946841 2 pooled tumors (clear cell type), Kidney .vd-u 82 to 492 422 to 11   tiling clone, AAA   412/412
(100 %)
2 diff
(99.6 %id)
BG940562 blood .vd-u 107 to 408 18 to 316       299/316
(94 %)
6 diff
(98.2 %id)
AW073069 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .vd-u 107 to 495 387 to 2   tiling clone,   386/387
(99 %)
0 diff
(100 %id)
BG940563 blood .vd-u 271 to 484 238 to 25   AAA   214/241
(88 %)
0 diff
(100 %id)
AI887609 serous papillary carcinoma, high grade, 2pooled tumors, uterus .ve 1 to 444 444 to 1 exact tiling clone,   444/444
(100 %)
0 diff
(100 %id)
AA280241 germinal center B cell .vf 1 to 147 148 to 5 Q17N N18R R19I I21Q Q22T ... tiling clone, Submitted on the opposite strand 144/148
(97 %)
0 diff
(100 %id)
BQ339110 nervous_normal Gene FUS, variant not shown         This clone was ignored    
BQ339589 nervous_normal Gene FUS, variant not shown         This clone was ignored    
BX456445 thymus Gene FUS, variant not shown              
EG327459 pooled Gene FUS, variant not shown         Submitted on the opposite strand    
AA401902   Gene FUS, variant not shown              
AA412717   Gene FUS, variant not shown              
BG696238 skin Gene FUS, variant not shown              
TI_154122488   Gene FUS, variant not shown         This clone was ignored    
248 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p, .q, .r-u, .s, .t, .u, .va, .vb, .vc, .vd-u, .ve, .vf Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI